You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carbidopa-Levodopa Extended-Release Tablets

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal

Completed
Has Results
  • Advanced Parkinson's Disease
  • Levodopa-Carbidopa Intestinal Gel
  • +2 more
  • (no location specified)
Jul 14, 2021

Small Intestine and Blood Fingerprint Study in Parkinson's

Not yet recruiting
  • Parkinson Disease
  • Fluid biopsy capsule
  • Levodopa-Carbidopa Immediate Release
  • Calgary, Alberta, Canada
    University of Calgary
Aug 15, 2023

Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)

Recruiting
  • Late Life Depression
  • +4 more
  • Nashville, Tennessee
    Vanderbilt Psychiatric Hospital
Feb 23, 2022

Parkinson's Disease, Levodopa Induced Dyskinesias (LID) Trial in Worldwide (240mg Amantadine HCl ER tablets, Placebo tablets,

Terminated
Has Results
  • Parkinson's Disease
  • Levodopa Induced Dyskinesias (LID)
  • 240mg Amantadine HCl ER tablets
  • +2 more
  • Tucson, Arizona
  • +55 more
Feb 14, 2022

Parkinson's Disease, Levodopa Induced Dyskinesia (LID) Trial in Worldwide (amantadine HCl ER, Placebo)

Terminated
Has Results
  • Parkinson's Disease
  • Levodopa Induced Dyskinesia (LID)
  • amantadine HCl ER
  • Placebo
  • Tucson, Arizona
  • +55 more
Feb 14, 2022

Kidney Transplant; Complications Trial in Philadelphia (Extended Release Tacrolimus Tablets, Immediate Release Tacrolimus

Recruiting
  • Kidney Transplant; Complications
  • Extended Release Tacrolimus Tablets
  • Immediate Release Tacrolimus Capsule
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Feb 2, 2022

Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)

Completed
Has Results
  • Advanced Parkinson's Disease
  • Little Rock, Arkansas
  • +10 more
May 11, 2022

MDD (MDD) Trial in Beijing (LY03005 extended-release tablet, Placebo)

Completed
  • Major Depressive Disorder (MDD)
  • LY03005 extended-release tablet
  • Placebo
  • Beijing, China
    The Sixth Hospital of Peking University
Nov 11, 2021

Opioid Dependence Trial in New York (Buprenorphine Extended Release, Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic

Completed
Has Results
  • Opioid Dependence
  • Buprenorphine Extended Release
  • Sublingual Buprenorphine (SUBOXONE, Zubsolv, or generic tablets)
  • New York, New York
    Bellevue Hospital Center
Dec 13, 2021

Hypercholesterolemia, Hyperlipidemia Trial (Vytorin + Niaspan, Vytorin, Niaspan)

Completed
  • Hypercholesterolemia
  • Hyperlipidemia
  • Vytorin + Niaspan
  • +2 more
  • (no location specified)
Feb 7, 2022

Idiopathic Pulmonary Fibrosis Trial (nalbuphine ER, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • nalbuphine ER
  • Placebo
  • (no location specified)
Jul 19, 2023

Age-related Macular Degeneration Trial in Tucson (carbidopa-levodopa 25-100 mg tablets)

Completed
  • Age-related Macular Degeneration
  • carbidopa-levodopa 25-100 mg tablets
  • Tucson, Arizona
    Robert W Snyder, MD, PhD, PC
Dec 10, 2020

Nocturnal Enuresis Trial in Banha (desmopressin 120 mcg oral tablets, Mirabegron 25 MG Oral Tablet, Extended Release, behavioral

Recruiting
  • Nocturnal Enuresis
  • desmopressin 120 mcg oral tablets
  • +2 more
  • Banhā, Qaliopia, Egypt
    Benha University Hospitals
Nov 29, 2022

HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection

Completed
  • HIV Infections
  • Cabotegravir Tablets
  • +3 more
  • Glendale, California
    GSK Investigational Site
Feb 14, 2022

Parkinson Disease Trial (WD-1603)

Unknown status
  • Parkinson Disease
  • (no location specified)
Sep 18, 2020

Healthy Trial in Cairo (Ekmasonid, Uceris (first dose), Uceris (second dose))

Completed
  • Healthy
  • Cairo, Egypt
    Genuine Research Center GRC
Apr 18, 2021

Opioid Use, Opioid Dependence, Opioid-use Disorder Trial in Chicago (Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet, Naproxen 500

Recruiting
  • Opioid Use
  • +10 more
  • Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet
  • +2 more
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Jul 13, 2022

Parkinson's Disease (Disorder) Trial in Worldwide (IR CD-LD, IPX203 ER CD-LD, IPX203 )

Completed
  • Parkinson's Disease (Disorder)
  • IR CD-LD
  • +3 more
  • Phoenix, Arizona
  • +107 more
Jul 22, 2021

Multiple Sclerosis, Spasticity, Muscle Trial in Worldwide (Arbaclofen, Placebo)

Completed
Has Results
  • Multiple Sclerosis
  • Spasticity, Muscle
  • Grodno, Belarus
  • +29 more
Jul 12, 2022

Sub-acute Back Pain Trial in Chicago (Naproxen, Carbidopa/Levodopa, Placebo)

Completed
Has Results
  • Sub-acute Back Pain
  • Chicago, Illinois
    Northwestern University Feinberg School of Medicine
Mar 2, 2021

Bioequivalence Trial in Mount Royal (Lamotrigine ER tablet 50mg)

Completed
  • Bioequivalence
  • Lamotrigine ER tablet 50mg
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Dec 6, 2021

Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

Completed
  • Nalbuphine
  • +2 more
  • Nalbuphine ER
  • Placebo oral tablet
  • Antrim, Northern Ireland, United Kingdom
  • +14 more
Oct 3, 2022

Pain Trial in United States (Ibuprofen 600 mg Immediate Release/Extended Release Caplet)

Terminated
Has Results
  • Pain
  • Ibuprofen 600 mg Immediate Release/Extended Release Caplet
  • Hoover, Alabama
  • +26 more
Aug 27, 2021

Hypertension in Pregnancy Trial in Durham (Nifedipine Extended-Release Tablets, No Antihypertensive Medication)

Terminated
  • Hypertension in Pregnancy
  • Nifedipine Extended-Release Tablets
  • No Antihypertensive Medication
  • Durham, North Carolina
    Duke University
Feb 1, 2022

Neurogenic Detrusor Overactivity Trial in Brussels (4 mg Fesoterodine ER tablet from Zwickau, 4 mg fesoterodine ER tablet from

Completed
  • Neurogenic Detrusor Overactivity
  • 4 mg Fesoterodine ER tablet from Zwickau
  • +3 more
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
May 6, 2021